| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts;
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and
Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer-Sheba, Israel.
Correspondence to Dr. Wolfgang C. Winkelmayer, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Womens Hospital, 221 Longwood Avenue, BLI/341, Boston, MA 02115. Phone: 617-278-0036; Fax: 617-232-8602; E-mail: wolfgang{at}post.harvard.edu
ABSTRACT. The objective of this study was to evaluate differences in mortality over the first year of renal replacement therapy (RRT) between elderly patients starting treatment on hemodialysis (HD) versus peritoneal dialysis (PD). For the period of 1991 to mid-1996, this study defined an inception cohort of all patients aged >65 yr with new-onset chronic RRT who were New Jersey Medicare and/or Medicaid beneficiaries in the year before RRT and who had been diagnosed with renal disease more than 1 yr before RRT. Propensity scores were calculated for first treatment assignment from a large number of baseline covariates. Mortality was then compared among patients initially assigned to HD versus PD using multivariate 90-d interval Cox models controlled for propensity scores and center stratification. Peritoneal dialysis starters had a 16% higher rate of death during the first 90 d of RRT compared with HD patients (hazard ratio [HR], 1.16; 95% confidence interval [CI], 0.96 to 1.42)]. Mortality did not differ between day 91 and 180 (HR, 1.03; 95% CI, 0.71 to 1.51). Thereafter, PD starters again died at a higher rate (HR, 1.45; 95% CI, 1.07 to 1.98). These findings were more pronounced among patients with diabetes. Sensitivity analyses using more stringent criteria to ensure that first treatment choice reflected long-term treatment choice confirmed the presence of an association between PD and mortality. In conclusion, compared with HD, peritoneal dialysis appears to be associated with higher mortality among older patients, particularly among those with diabetes, even after controlling for a large number of risk factors for mortality, propensity scores to control for nonrandom treatment assignment, and center stratification.
This article has been cited by other articles:
![]() |
M. B Nichol, T. K Knight, T. Dow, G. Wygant, G. Borok, O. Hauch, and R. O'Connor Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care Ann. Pharmacother., January 1, 2008; 42(1): 62 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couchoud, O. Moranne, L. Frimat, M. Labeeuw, V. Allot, and B. Stengel Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3246 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Inrig, J. L. Sun, Q. Yang, L. P. Briley, and L. A. Szczech Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Roberts, R. N. Foley, E. D. Weinhandl, D. T. Gilbertson, and A. J. Collins Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1652 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Ann Intern Med, August 2, 2005; 143(3): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Wu, N. E. Fink, J. V.R. Marsh-Manzi, K. B. Meyer, F. O. Finkelstein, M. M. Chapman, and N. R. Powe Changes in Quality of Life during Hemodialysis and Peritoneal Dialysis Treatment: Generic and Disease Specific Measures J. Am. Soc. Nephrol., March 1, 2004; 15(3): 743 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Polkinghorne, S. P. McDonald, R. C. Atkins, and P. G. Kerr Vascular Access and All-Cause Mortality: A Propensity Score Analysis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2 J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673